Breast Cancer Risk Reduction in Postmenopausal Women At Risk
📧 Sign up to get email alerts when something new happens for Breast Cancer Risk Reduction in Postmenopausal Women At Risk.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-03-22FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's original application for raloxifene hydrochloride (generic) for postmenopausal osteoporosis and for reducing the ris…